Skip to main content

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Filters
Recall details
Location
Date range
Clear filters

Showing 7,441–7,460 of 17,964 drug recalls

Drug Recall Terminated Historical recordClass II

Adult Glycerin Suppositories, Package Size 100-count suppositories, Distributed By: Walgreen Co. 200 Wilmot Rd. Deerfield, IL 60015. NDC#0363-0441-00

by US Pharmaceuticals Inc.

Reason
CGMP Deviations: Out of Specification results for either total microbial count or total organic carbon in the purified water utilized in the manufacturing process.
Recall initiated
July 11, 2019
Reported by FDA
August 21, 2019
Distribution
Distributed Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

Adult Glycerin Suppositories, Package Size 50-count suppositories, Distributed By: Walgreen Co. 200 Wilmot Rd. Deerfield, IL 60015. NDC#0363-0441-50

by US Pharmaceuticals Inc.

Reason
CGMP Deviations: Out of Specification results for either total microbial count or total organic carbon in the purified water utilized in the manufacturing process.
Recall initiated
July 11, 2019
Reported by FDA
August 21, 2019
Distribution
Distributed Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

Adult Glycerin Suppositories, Package Size 25-count suppositories, Distributed By: Walgreen Co. 200 Wilmot Rd. Deerfield, IL 60015. NDC#0363-0445-25,

by US Pharmaceuticals Inc.

Reason
CGMP Deviations: Out of Specification results for either total microbial count or total organic carbon in the purified water utilized in the manufacturing process.
Recall initiated
July 11, 2019
Reported by FDA
August 21, 2019
Distribution
Distributed Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

Children Glycerin Suppositories Laxative for ages 2 to 5. Package Size 25-count.Distributed by Walgreen CO. 200 Wilmot Rd. Deerfield IL 60015. NDC#0363-0440-25,

by US Pharmaceuticals Inc.

Reason
CGMP Deviations: Out of Specification results for either total microbial count or total organic carbon in the purified water utilized in the manufacturing process.
Recall initiated
July 11, 2019
Reported by FDA
August 21, 2019
Distribution
Distributed Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

CVS Therapeutic Menthol Gel, 8 FL OZ (227 g) Distributed by: CVS Pharmacy, Inc. One CVS Drive Woonsocket, RI 02895. UPC 0 50428 48136 3

by US Pharmaceuticals Inc.

Reason
CGMP Deviations: Out of Specification results for either total microbial count or total organic carbon in the purified water utilized in the manufacturing process.
Recall initiated
July 11, 2019
Reported by FDA
August 21, 2019
Distribution
Distributed Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

Eczema Lotion Hydrocortisone 1% / Anti-Itch Lotion, 3.5 oz (99.2 g) Distributed By: Walgreen Co. 200 Wilmot Rd. Deerfield, IL,60015. NDC 0363-0670-04, UPC 3 11917 19308 3

by US Pharmaceuticals Inc.

Reason
CGMP Deviations: Out of Specification results for either total microbial count or total organic carbon in the purified water utilized in the manufacturing process.
Recall initiated
July 11, 2019
Reported by FDA
August 21, 2019
Distribution
Distributed Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

CVS Health Glycerin Suppositories, 50-count box, Distributed by: CVS Pharmacy, Inc. One CVS Drive Woonsocket, RI 02895. UPC 0 50428 33106 4

by US Pharmaceuticals Inc.

Reason
CGMP Deviations: Out of Specification results for either total microbial count or total organic carbon in the purified water utilized in the manufacturing process.
Recall initiated
July 11, 2019
Reported by FDA
August 21, 2019
Distribution
Distributed Nationwide in the USA

View recall →

Drug Recall Terminated Historical recordClass II

Macrobid Urinary Tract Anitbacterial, 100 mg, 100-count bottle, Rx Only, Mfg. by: Norwich Pharmaceuticals, Inc. Norwich, NY 13815 USA Dist. by: Almatica Pharma, Inc. Pine Brook, NJ 07058 USA, NDC 52427-285-01

by Alvogen, Inc

Reason
Failed dissolution specifications
Recall initiated
July 24, 2019
Reported by FDA
August 21, 2019
Distribution
Natonwide, PR

View recall →

Drug Recall Terminated Historical recordClass II

Nitrofurantoin Monohydrate/Macrycrystals Capsules, 100 mg, 100-count bottle, Rx Only, Distributed by: Alvogen, Inc. Pine Brook, NY 07058 USA, NDC 47781-303-01

by Alvogen, Inc

Reason
Failed dissolution specifications
Recall initiated
July 24, 2019
Reported by FDA
August 21, 2019
Distribution
Natonwide, PR

View recall →

Drug Recall Terminated Historical recordClass II

Lisinopril and Hydrochlorothiazide Tablets USP, 10 mg/12.5 mg, 100 tablet bottle, Rx only, Manufactured by for: Lupin Pharmaceuticals, Inc., Baltimore, MD, Manufactured by: Lupin Limited, Pithampur, INDIA NDC 68180-518-01

by Lupin Pharmaceuticals Inc.

Reason
Presence of Foreign Substance; Product complaints received related to brownish/blackish stains on the tablets and brownish/blackish powder observed inside the bottles.
Recall initiated
July 17, 2019
Reported by FDA
August 21, 2019
Distribution
Product was distributed to wholesalers/distributors and supermarket and drug chains throughout the United States.

View recall →

Drug Recall Terminated Historical recordClass II

VITAMIN B COMPLEX 100 (PFV), [2 or 30 ML] per Vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC 2 ML Vial: 70731-0961-02; NDC 30 ML Vial: 70731-0961-30

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Recall initiated
June 19, 2019
Reported by FDA
August 14, 2019
Distribution
Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

STERILE WATER FOR INJECTION USP, [10, 30, or 50 ML] per Vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC 10 ML vial: 70731-0188-10; NDC 30 ML vial: 70731-0188-30; NDC 50 ML vial: 70731-0188-50

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Recall initiated
June 19, 2019
Reported by FDA
August 14, 2019
Distribution
Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

LIDOCAINE 0.75%/Epinephrine 0.025%/BSS 0.56ML SYR, 1 ML PER Syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0919-01

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Recall initiated
June 19, 2019
Reported by FDA
August 14, 2019
Distribution
Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

RXQ CAIN (PHENYLEP 1.5%/ LIDO 1% OPHTH SOL (PF), 1 ML PER VIAL, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0918-01

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Recall initiated
June 19, 2019
Reported by FDA
August 14, 2019
Distribution
Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

ROPIVICAINE 0.2%, INJ SOLN, 550 ML ON-Q PUMP. RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0238-55

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Recall initiated
June 19, 2019
Reported by FDA
August 14, 2019
Distribution
Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

PROCAINE HCL 20 MG/ML (MDV) INJECTABLE SOLUTION, 30 ML per vial. RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0987-30

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Recall initiated
June 19, 2019
Reported by FDA
August 14, 2019
Distribution
Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

PREDNISOLONE 1%, MOXIFLOXACIN 0.5% OPHTH SOL, 5ML per dropper bottle, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0109-05

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Recall initiated
June 19, 2019
Reported by FDA
August 14, 2019
Distribution
Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

POTASSIUM CHLORIDE 15% (2MEQ/ML) INJ SOLN, 30 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0954-30

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Recall initiated
June 19, 2019
Reported by FDA
August 14, 2019
Distribution
Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

PHENYLEPHRINE HCL 100 MCG/ML IN NACL 0.9% SYR, 10 ML per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0136-10

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Recall initiated
June 19, 2019
Reported by FDA
August 14, 2019
Distribution
Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

ONDANSETRON 2 MG/ML INJECTION SOLUTION (NPF), 20ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0157-20

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Recall initiated
June 19, 2019
Reported by FDA
August 14, 2019
Distribution
Nationwide USA

View recall →

Data last updated:

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.